SCHEMBL29479721

SCHEMBL29479721

CCOC(=O)c1cc(-c2nc3cc(-c4ccnn4C)ccc3o2)ccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 11/20 0.41
▸ RAB9A P51151 5/20 0.41
▸ TP53 P04637 5/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ KDM4E B2RXH2 4/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ HPGD P15428 4/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ CASP3 P42574 3/20 0.41
▸ SENP8 Q96LD8 3/20 0.41
▸ SENP7 Q9BQF6 3/20 0.41
▸ SENP6 Q9GZR1 3/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ NPC1 O15118 3/20 0.39
▸ POLB P06746 1/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ RXFP1 Q9HBX9 2/20 0.39
▸ UTRN P46939 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23012088 1.00 MAPT (0.41) MAPTRAB9ATP53SMN1; SMN2KDM4E
SCHEMBL29479803 0.86 MMP2 (0.51) MAPTRAB9ATP53SMN1; SMN2KDM4E
SCHEMBL23012957 0.86 MMP2 (0.51) MAPTRAB9ATP53SMN1; SMN2KDM4E
SCHEMBL28707166 0.86 HPSE (0.39) MAPTRAB9ATP53SMN1; SMN2KDM4E
SCHEMBL29479687 0.86 HPSE (0.39) MAPTRAB9ATP53SMN1; SMN2KDM4E
SCHEMBL23033644 0.86 HDAC6 (0.40) MAPTRAB9ATP53SMN1; SMN2KDM4E
SCHEMBL28714674 0.85 PIM1 (0.44) MAPTRAB9ATP53SMN1; SMN2KDM4E
SCHEMBL29479641 0.85 PIM1 (0.44) MAPTRAB9ATP53SMN1; SMN2KDM4E
SCHEMBL23012200 0.83 JMJD6 (0.48) MAPTRAB9ATP53SMN1; SMN2KDM4E
SCHEMBL28707215 0.83 MAPT (0.40) MAPTRAB9ATP53SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269725-B Anti-influenza virus compound, preparation method and application thereof 西藏海思科制药有限公司 2024-09-17 — — CN disclosed
US-20230079045-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-03-16 — — US disclosed
CN-114269725-A Anti-influenza virus compound and preparation method and application thereof 四川海思科制药有限公司 2022-04-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230079045-A1 ANTI-INFLUENZA VIRUS COMPOUND, PREPARATION METHOD AND USE THEREOF IDE, ACE, SI MAPT 2824/4885RAB9A 385/4885TP53 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback